#US20260327267
LightNews LightNews
interestingpatents.bsky.social
Targeting peptides inserted into surface-exposed AAV capsid regions are designed to help vectors cross the blood-brain barrier and transduce CNS cells. Sangamo Therapeutics patent application #US20260327267 #SangamoTherapeutics #GeneTherapy
Fig. 01 from patent document #US20260327267 Fig. 16 from patent document #US20260327267 Fig. 06 from patent document #US20260327267 Fig. 20 from patent document #US20260327267
October 26, 2026 at 3:21 AM